The roles of post-translational modifications in STAT3 biological activities and functions

A Tesoriere, A Dinarello, F Argenton - Biomedicines, 2021 - mdpi.com
STAT3 is an important transcription factor that regulates cell growth and proliferation by
regulating gene transcription of a plethora of genes. This protein also has many roles in …

[HTML][HTML] Targeting the STAT3 oncogenic pathway: Cancer immunotherapy and drug repurposing

Y Dong, J Chen, Y Chen, S Liu - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Immune effector cells in the microenvironment tend to be depleted or remodeled, unable to
perform normal functions, and even promote the malignant characterization of tumors …

TNK1 is a ubiquitin-binding and 14-3-3-regulated kinase that can be targeted to block tumor growth

TY Chan, CM Egbert, JE Maxson, A Siddiqui… - Nature …, 2021 - nature.com
TNK1 is a non-receptor tyrosine kinase with poorly understood biological function and
regulation. Here, we identify TNK1 dependencies in primary human cancers. We also …

[HTML][HTML] MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers

M Sajjadi-Dokht, TAM Mohamad, HS Rahman… - Genes & diseases, 2022 - Elsevier
Blood disorders include a wide spectrum of blood-associated malignancies resulting from
inherited or acquired defects. The ineffectiveness of existing therapies against blood …

Untwining anti-tumor and immunosuppressive effects of JAK inhibitors—a strategy for hematological malignancies?

K Klein, D Stoiber, V Sexl, A Witalisz-Siepracka - Cancers, 2021 - mdpi.com
Simple Summary The Janus kinase-signal transducer and activator of transcription (JAK-
STAT) pathway is aberrantly activated in many malignancies. Inhibition of this pathway via …

High prevalence of low-allele-fraction somatic mutations in STAT3 in peripheral blood CD8+ cells in multiple sclerosis patients and controls

M Valori, J Lehikoinen, L Jansson, J Clancy… - Plos one, 2022 - journals.plos.org
Somatic mutations have a central role in cancer, but there are also a few rare autoimmune
diseases in which somatic mutations play a major role. We have recently shown that …

Myeloproliferative and lymphoproliferative disorders: State of the art

E Rumi, C Baratè, G Benevolo, M Maffioli… - Hematological …, 2020 - Wiley Online Library
Myeloproliferative neoplasms (MPNs), including polycythemia vera (PV), essential
thrombocythemia (ET), and primary myelofibrosis (PMF), are clonal disorders complicated …

Rational targets of therapy in extranodal NK/T-cell lymphoma

A Major, P Porcu, BM Haverkos - Cancers, 2023 - mdpi.com
Simple Summary Extranodal NK/T-cell lymphoma (ENKTL) is an aggressive blood cancer
with poor survival rates, particularly for patients with advanced-stage and relapsed disease …

The constitutive activation of STAT3 gene and its mutations are at the crossroad between LGL leukemia and autoimmune disorders

G Semenzato, G Calabretto, A Teramo… - Blood Cancer …, 2024 - nature.com
Abstract Type T Large Granular Lymphocyte Leukemia (T-LGLL) is a chronic disorder
characterized by the abnormal proliferation of clonal cytotoxic T cells. The intriguing …

Identification of novel regulators of STAT3 activity

E Parri, H Kuusanmäki, AJ van Adrichem, M Kaustio… - PloS one, 2020 - journals.plos.org
STAT3 mediates signalling downstream of cytokine and growth factor receptors where it acts
as a transcription factor for its target genes, including oncogenes and cell survival regulating …